Technology Commercialization Technology CommercializationTechnology CommercializationTechnology Commercializtion
Opportunities for Investors/Entrepreneurs For Industry
Felder & GuptaCircuit boardLandersNanotechnologyNadler
Message from the VP
T1000 Alumni Mentoring
Southwest Virginia Economic Development Program
Research at U.Va.
Office of the VP for Research
Policies & Forms
Policies & Forms

 

Contact Us
P.O. Box 400301
Charlottesville, VA
22904-4301
434-924-7566
Office Staff >>

 

Archived News

Charlottesville Tomorrow reports on the Defense Intelligance Agency's move to the region (11.19.10)

Several UVa companies have received grants under the Qualifying Therapeutic Discovery Project Tax Credit program (11.01.10)

New Weldon Cooper study on Workforce Readiness shows employers value honesty, social skills and a positive work ethic (10.29.10)

Virginia Business Magazine highlights UVa's unique partnership with Rolls Royce and Virginia Tech as "a national model for manufacturing growth" having groundbreaking importance to investment and strategic research directions (10.28.10)

HemoSonics has secured $2M in SBIR and STTR funding to develop the Global Hemostasis Analyzer (10.7.10)

PluroGen signs $8.6 million contract with Dept. of Defense as part of the Limb Salvage and Regenerative Medicine initiative (9.1.10)

UVa Computer Scientist, Kim Hazelwood, has been recognized by MIT's Technology Review as one of the world's top young innovators (8/27/10)

U.Va. Start-Up EpiEP receives $1.5 million investment to advance its EpiAccess system to improve treatment of cardiac arrhythmia (7/8/10)

The New York Times features Mark Crowell, Associate VP for Innovation Partnerships, and U.Va. start-up, HemoShear, in The Idea Incubator Goes to Campus (6/28/10)

DVTI, Adenosine Therapeutics and ContraVac featured in national report on economic benefits of federally-funded research (6/17/10)

U.Va. start-ups, ContraVac, HemoShear and Global Cell Solutions, and alum, Robert Capon, honored at the Charlottesville Innovation Awards (6/2/10)

Mark Crowell named UVa's first Executive Director of Innovation Partnerships (5/3/10)

The University of Virginia Patent Foundation has named Kevin Lynch and Timothy Macdonald the 2010 Edlich-Henderson Inventors of the Year (4/6/10)

U.Va.'s 2nd Annual Venture Summit brings together venture capitalists representing nearly $2 billion in active capital funds (3.26.10)

"Early Stage Deal of the Year" runner-up has roots at U.Va. (3.12.10)

Global Cell Solutions' Benchtop BioLevitator is one of 2009's most exciting life science tools (1.05.10)

WellAWARE Systems, a Charlottesville developer of monitoring systems for senior care providers, closes $7.5 million of growth capital (12.11.09)

U.Va. start-up, Diakine Therapeutics, recognized as a leading life science innovator (12.08.09)

DIA bringing jobs, technology development to Charlottesville (11.22.09)

Tau Therapeutics advances brain cancer therapy (10.3.09)

Charlottesville named one of the best places to launch a business and UVa plays key role (11.09)

UVa projects and faculty honored by Charlottesville Business Innvoation Council (CBIC) (5.21.09)

PluroGen Therapeutics' gel lessens burn dressing pain (9.28.08)

Bluetree Allied Angels invest in UVa start-up (9.03.08)

UVa Patent Foundation licenses silver nanoparticle technology to UVa start-up PluroGen Therapeutics (04.21.08)

Sperm-check home test receives FDA OK (03.05.08)

Landers receives ALA Innovation Award at LabAutomation 2008 (02.07.08)

PluroGen Therapeutics partners with Welcare Industries (12.27.07)

PocketMed releases new hand-held software (11.29.07)

DiaKine Therapeutic's anti-diabetes drug featured in report to Congress (10.25.07)

T100 Company honored with VPTC-CVG Breakthrough Award (06.06.07)

 

 

spacer
spacer
 
spacer